August 17, 2026
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced a global collaboration and license agreement with Eli Lilly and Company (Lilly) for a new ion channel program.
The collaboration leverages OmniAb’s technology platform and expertise in ion channel discovery and screening.
“We are pleased to enter into this important new relationship with Lilly,” said Matt Foehr, OmniAb’s Chief Executive Officer.
“Lilly is focused on delivering medicines to address major unmet medical needs, and our differentiated expertise and established technologies that relate to ion channels are well positioned to help drive this new discovery program.”
Under the terms of the agreement, OmniAb will receive an upfront payment and is eligible to receive up to $370 million in research, development, and commercial milestone payments, as well as tiered royalties on global net sales. The therapeutic target and modality are undisclosed. BusinessWire reports.
☁️ HIVE Stock Jumps After AI Cloud Deal — Here’s Why
The cluster is expected to become operational later in 2026 at the Bell AI Fabric facility in Merritt, British Columbia.
The facility runs on 100% renewable hydroelectric power and uses closed-loop liquid cooling that eliminates ongoing water consumption for cooling.
With S&P 500 futures up about 0.2% in premarket trading, HIVE’s roughly 9% gain highlights investor reaction to the company’s expanded contracted AI infrastructure revenue. Benzinga reports.
📰 Dow, S&P 500, Nasdaq Futures Waver Ahead of Retail Earnings
US stock futures wavered on Monday as investors weighed the Federal Reserve's next policy move and awaited a slate of retail earnings this week.
Futures on the Dow Jones Industrial Average (YM=F) slipped 0.1%. Those on the S&P 500 (ES=F) traded near the flat line after the benchmark index posted its third straight weekly gain. Contracts for the Nasdaq-100 (NQ=F) rose 0.4% after a relatively calm week on Wall Street.
Investor attention turns toward retail earnings and oil prices this week, with fewer market-moving economic data releases on the calendar. Big-box stores, including Walmart (WMT), Target (TGT), Lowe's (LOW), and Home Depot (HD), report quarterly results this week, providing insights into consumer health during the important back-to-school shopping season.
Traders, meanwhile, pulled back the odds of a September rate hike at the Fed's Jackson Hole meeting to less than one-third, as inflation and jobs data have created a mixed economic picture.
Oil prices remain a key factor for markets and the Fed as the US takes an economic approach to the war in the Middle East. Brent crude (BZ=F) futures, the international benchmark, edged up to $88 per barrel on Monday. At the same time, financial markets have tightened, with the 10-year (^TNX) and 30-year (^TYX) Treasury yields rising 5 basis points as of Friday's close.
The Federal Open Market Committee meeting minutes, released on Wednesday, could offer more clues into Fed officials' thinking. YahooFinance reports.
🧾 XP, Fabrinet and 3 Stocks to Watch Heading Into Monday
With U.S. stock futures trading mixed on Monday, several companies are drawing attention around upcoming and recently released earnings.
XP Inc. is expected to report quarterly earnings of 51 cents per share on revenue of $976.54 million after the closing bell, while Fabrinet is expected to post earnings of $3.82 per share on revenue of $1.27 billion.
Bally’s Corp. reported a second-quarter loss of $2.41 per share, missing expectations, although revenue came in above estimates. Shares fell 8.2% in after-hours trading.
HIVE Digital Technologies also missed first-quarter earnings and revenue estimates, with shares falling 4.1% after hours. Meanwhile, Flexsteel Industries is expected to report earnings of $1.09 per share on revenue of $109.66 million after the close. Benzinga reports.
🧠 Stripe Nears $7 Billion-Plus OpenRouter Acquisition as Payments Giant Deepens AI Push
Stripe is reportedly nearing a deal to acquire OpenRouter for more than $7 billion, marking one of the payments giant’s largest moves into artificial intelligence infrastructure.
The final acquisition price could still change, according to Bloomberg. OpenRouter raised a $120 million Series B round in May at a $1.3 billion valuation, with backing from Alphabet’s CapitalG, Sequoia, Andreessen Horowitz, and Menlo Ventures.
The two companies already have a commercial relationship, with OpenRouter using Stripe’s payment infrastructure to process customer transactions. Benzinga reports.
🍔 20 Reasons Why Wendy’s May Be Doomed
Wendy’s is facing mounting pressure as the fast-food chain struggles with declining sales, weaker profitability, restaurant closures, and increased competition. The company has recorded six consecutive quarters of same-store sales declines, with U.S. same-restaurant sales falling 7% in the second quarter and adjusted operating profit dropping 13.2% year over year.
During the first half of the year, 289 U.S. Wendy’s locations closed, adding pressure on franchisees already dealing with weaker restaurant-level profitability. The company is also facing stronger competition from Burger King and McDonald’s, while another leadership change has brought former Wendy’s executive Bob Wright back as CEO.
Wendy’s shares have fallen about 65% over the past five years, while the company has withdrawn its FY26 guidance. Net leverage stands at 5.0x, which could limit how quickly management can invest in a turnaround.
At the same time, investor Nelson Peltz and a consortium are reportedly considering taking Wendy’s private, potentially creating a major strategic shift for the struggling restaurant chain. YahooFinance reports.
(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.
1) IPST: IP Strategy Holdings, Inc.
Total gain: +3.25 (147.72%)
2) SLE: Super League Enterprise, Inc.
Total gain: +0.690 (30.40%)
3) XPON: Expion360 Inc.
Total gain: +0.830 (22.80%)
4) OABI: OmniAb, Inc.
Total gain: +0.560 (16.57%)
5) NNNN: Anbio Biotechnology
Total gain: +1.70 (19.45%)
The closing price of the top three market percent gainers trading near or above $3 on Aug 14.
(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET) Stock Analysis reports.
1) PFSA: Profusa, Inc.
Total gain: +2.649 (278.62%)
The company announced that it led an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to elect a one-for-four reverse stock split of its common stock. The reverse stock split will take elect on August 17, 2026, and the Company’s common stock will open for trading on The Nasdaq Capital Market on August 17, 2026 on a post-split basis, under the existing ticker symbol “PFSA” but with a new CUSIP number. TipRanks reports.
2) WETO: Wetour Robotics Limited
Total gain: +4.61 (127.70%)
The stock appeared to be moving on no notable news.
3) MDXH: MDxHealth SA
Total gain: +0.3460 (74.89%)
The company announced Q2 results and reiterated guidance. The firm is lowering its price target to reflect the increased share count from the registered direct offering but says that “with the PROMPT publication in hand and the landmark PROTECT readout ahead, we believe the pieces are falling back into place” and it would be buyers of the shares. TipRanks reports.
(Estimate and Actual numbers represent Earnings Per Share in US Dollars)
DUOT
Duos Technologies Group
Q2 2026
After Market Close
Estimate: 0.520
Actual: N/A
NSPR
InspireMD
Q2 2026
Before Market Open
Estimate: -0.200
Actual: N/A
DCGO
DocGo
Q2 2026
After Market Close
Estimate: -0.130
Actual: N/A
Time (ET) / Report / Period
“One investment rule at Berkshire has not and will not change: Never risk permanent loss of capital.”
– Warren Buffett
Sourced in: Berkshire Hathaway 2023 Annual Letter to Shareholders
TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).
TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.
The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.
Investing involves risk, including the possible loss of principal.
There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.
Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.
Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.
Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.
Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.
If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.
Copyright © TradeZero 2026. All rights reserved.